[Federal Register Volume 74, Number 248 (Tuesday, December 29, 2009)]
[Notices]
[Page 68801]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-30754]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning an Anti-
Relapse Treatment and Prophylaxis for Malaria

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/261,872 entitled ``* * * as an Anti-Relapse Treatment and 
Prophylaxis for Malaria,'' filed November 17, 2009. The United States 
Government, as represented by the Secretary of the Army, has rights to 
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Assessment, (301) 619-6664, 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to the use of an 
approved anticoccidial drug that is currently used in veterinary 
medicine in feed stocks, as an anti-relapse treatment and prophylaxis 
for malaria.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E9-30754 Filed 12-28-09; 8:45 am]
BILLING CODE 3710-08-P